Stockreport

How The Advanced Enzyme Technologies (NSEI:ADVENZYMES) Story Is Shifting With An Unchanged ?370 Valuation [Yahoo! Finance]

Advantage Solutions Inc. - Class A  (ADV) 
PDF The fair value estimate for Advanced Enzyme Technologies stays at ?370.0, with analysts deciding not to shift the price target despite refreshed model inputs. Supportiv [Read more]